Best Biotechnology Stocks 2026
Top biotechnology stocks including gene therapy, immunotherapy, rare disease treatments, and innovative biotech companies.
Biotechnology companies develop innovative therapies using biological processes. These high-risk, high-reward investments focus on novel treatments for cancer, rare diseases, autoimmune disorders, and genetic conditions.
Top 24 Biotechnology Stocks to Buy
Vertex Pharmaceuticals Inc
Biotechnology
Market Cap
$106.87B
P/E Ratio
29.67
CSL Limited
Biotechnology
Market Cap
$77.47B
P/E Ratio
27.91
CSL Ltd
Biotechnology
Market Cap
$75.48B
P/E Ratio
28.55
Regeneron Pharmaceuticals Inc
Biotechnology
Market Cap
$59.10B
P/E Ratio
13.91
argenx NV ADR
Biotechnology
Market Cap
$52.35B
P/E Ratio
37.26
Alnylam Pharmaceuticals Inc
Biotechnology
Market Cap
$42.26B
P/E Ratio
—
UCB SA
Biotechnology
Market Cap
$37.99B
P/E Ratio
30.89
argenx SE
Biotechnology
Market Cap
$34.75B
P/E Ratio
34.73
BeiGene Ltd.
Biotechnology
Market Cap
$27.65B
P/E Ratio
—
Moderna Inc
Biotechnology
Market Cap
$24.52B
P/E Ratio
—
BioNTech SE
Biotechnology
Market Cap
$24.26B
P/E Ratio
—
Incyte Corporation
Biotechnology
Market Cap
$20.45B
P/E Ratio
14.46
Royalty Pharma Plc
Biotechnology
Market Cap
$20.45B
P/E Ratio
14.84
Insmed Inc
Biotechnology
Market Cap
$20.42B
P/E Ratio
—
Innovent Biologics Inc
Biotechnology
Market Cap
$17.76B
P/E Ratio
146.29
IVBIY
Biotechnology
Market Cap
$16.36B
P/E Ratio
—
Genmab A/S
Biotechnology
Market Cap
$15.96B
P/E Ratio
19.76
Jazz Pharmaceuticals PLC
Biotechnology
Market Cap
$14.97B
P/E Ratio
1988.08
Ascendis Pharma AS
Biotechnology
Market Cap
$14.74B
P/E Ratio
27.07
WuXi Biologics
Biotechnology
Market Cap
$13.58B
P/E Ratio
28.91
BridgeBio Pharma Inc
Biotechnology
Market Cap
$13.24B
P/E Ratio
—
Exelixis Inc
Biotechnology
Market Cap
$12.69B
P/E Ratio
16.72
Ionis Pharmaceuticals Inc
Biotechnology
Market Cap
$12.28B
P/E Ratio
—
Axsome Therapeutics Inc
Biotechnology
Market Cap
$12.07B
P/E Ratio
—
Stock terminals
More Biotechnology Stocks
Frequently Asked Questions
What are the best biotech stocks?
Top biotech stocks include Vertex Pharmaceuticals (VRTX) for cystic fibrosis, Regeneron (REGN) for antibody therapies, Moderna (MRNA) for mRNA technology, Amgen (AMGN) for established biologics, and Gilead (GILD) for HIV/HCV treatments. Evaluate clinical pipeline and FDA approval timelines.
Are biotech stocks risky?
Yes, biotech stocks carry significant risk due to binary clinical trial outcomes, FDA approval uncertainty, and potential competition. A failed Phase 3 trial can cause 50-90% stock drops. Diversification and understanding clinical trial data are essential for biotech investing.
How do you value biotech stocks?
Pre-revenue biotechs are valued on pipeline potential using risk-adjusted NPV of drug candidates, cash runway, and probability of approval. Profitable biotechs use traditional metrics like P/E, EV/Sales, and cash flow. Understanding drug economics and market size is critical.
What makes a good biotech investment?
Look for: validated science (peer-reviewed data), strong clinical trial results, experienced management, adequate cash runway, large addressable markets, and competitive advantages (patents, data exclusivity). Understand the therapeutic area and competitive landscape.
Related Industries
Get AI-Powered Stock Analysis
Access detailed DCF valuations, AI insights, and comprehensive analysis for biotechnology stocks
Start Research